Acura Pharmaceuticals Inc logo

Acura Pharmaceuticals Inc

$ 0.01 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
5.00
Market Cap:
$ 651.00K
Enterprise V:
$ 886.00K
Volume:
150.00
Avg Vol (2M):
45.05K
Also Trade In:
Volume:
150.00
Market Cap $:
651.00K
PE Ratio:
At Loss
Avg Vol (2-Month):
45.05K
Enterprise Value $:
886.00K
PB Ratio:
5.00
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Acura Pharmaceuticals Inc is a specialty pharmaceutical company based in the United States. It is engaged in the research, development, and commercialization of technologies and products intended to address medication abuse and misuse. The company's product portfolio includes Limitx, Oxaydo, and Nexafed.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.28
Equity-to-Asset 0.1
Debt-to-Equity 2.4
Debt-to-EBITDA -0.43
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -388.63
Distress
Grey
Safe
Beneish M-Score -5.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 59.55
9-Day RSI 31.78
14-Day RSI 27.59
6-1 Month Momentum % -97.5
12-1 Month Momentum % -98.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.86
Quick Ratio 0.86
Cash Ratio 0.09
Days Sales Outstanding 134.49

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.4

Financials

ACUR's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ACUR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.245
EPS (TTM) ($) -0.033
Beta 0.09
Volatility % 122.65
14-Day RSI 27.59
14-Day ATR ($) 0.007138
20-Day SMA ($) 0.009
12-1 Month Momentum % -98.18
52-Week Range ($) 0.0012 - 0.6
Shares Outstanding (Mil) 65.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acura Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Acura Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.